AUM Biosciences and Asymchem Complete Phase II API Production Campaign of Novel TRK Inhibitor
The collaboration resulted in a more robust manufacturing process for the novel TRK inhibitor. Asymchem, a leading global contract development and manufacturing service provider, and AUM Biosciences...